NSE filing, NSE: ARTEMISMED. Summary written from the filing by ALFA Finder's alert engine.
Artemis Medicare Services Ltd: key numbers
- Share price
- ₹298.55
- Market cap
- ₹4,726 Cr
- Revenue (annual)
- ₹1,081 Cr
- Net profit (annual)
- ₹103.6 Cr
- P/E (TTM)
- 41.6×Sector 52.0×
- Promoter holding
- 58.39%+0.00% QoQ
- FII holding
- 12.45%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Artemis Medicare Services Ltd
All →Artemis Medicare Services Board Meeting Date
Artemis Medicare scheduled a board meeting for Oct 30, 2026 to approve Q1 un-audited results. Trading window remains closed until Nov 1, 2026.
Artemis Medicare Services Other Announcement
Artemis Medicare Services Ltd submitted its quarterly shareholding pattern for the period ending September 30, 2026, in compliance with SEBI regulatory requirements.
Artemis Medicare Services Legal & Regulatory
Artemis Medicare received a Rs. 11.11 Crore Show Cause Notice from the GST department. The company is contesting this through a writ petition.
- Value
- ₹11.11 Cr
Artemis Medicare Services Credit Rating
CARE Ratings reaffirmed Artemis Medicare's bank facility ratings at CARE A with Stable outlook. Long-term and short-term facilities totalling ₹388.15 Cr were reviewed.
Artemis Medicare Services Earnings Call Transcript: Key Takeaways
Artemis reports strong Q1 FY27 growth, driven by Gurgaon performance and the Raipur hospital launch. Management is pivoting toward high-end quaternary care with a massive 2,000-bed expansion target by 2030.
Artemis Medicare Services Capacity Expansion: ₹180 Cr Investment
Artemis Medicare Services will invest ₹180 Crore to add 200+ beds at its Gurugram hospital, focusing on pediatric and gynecological services.
- Value
- ₹180.0 Cr
- Execution
- ~ 2 years
Other board meeting date announcements
All →RateGain Travel Technologies Board Meeting Date
RateGain Travel Technologies will hold a board meeting on 5 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window closes from 1 October 2026 until 48 hours after results.
Tapi Fruit Processing Board Meeting Date
Tapi Fruit Processing will hold a board meeting on November 3, 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closes from October 1 to November 5, 2026.
Parag Milk Foods Board Meeting Date
Parag Milk Foods has notified BSE of a board meeting on 3 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. Trading window closure runs from 1 October to 5 November 2026.
Vedant Fashions Board Meeting Date
Vedant Fashions will hold a board meeting on 5 November 2026 to consider unaudited results for the quarter and half-year ended September 2026. The meeting is a prior intimation, so no results are approved yet.
Dangee Dums Board Meeting Date
Dangee Dums will hold a board meeting on 2 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. Trading window closure runs until 4 November 2026.
Relic Technologies Board Meeting Date
Relic Technologies intimated a board meeting on 2 Nov 2026 to consider unaudited standalone and consolidated Q2 results for the period ended 30 Sep 2026. The trading window closes from 1 Oct 2026 until 48 hours after the results are disseminated.